| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/16/2005 | CN1189170C Thienylazolylal coxyethanamines, their preparation and their application as medicaments |
| 02/16/2005 | CN1189169C Dibenzo [a, KI] xanthene derivative used as anti-liver-cancer medicine |
| 02/16/2005 | CN1189168C Use of (-)-(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2-diabetes, hyperlipidemia and hyperuricemia |
| 02/16/2005 | CN1189167C Compound amino acid injecta and its prepn process |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/16/2005 | CN1189165C Fast-acting analgesic |
| 02/16/2005 | CN1189163C Adhesive preparations |
| 02/16/2005 | CN1189161C Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral adminisration thereof |
| 02/16/2005 | CN1189159C Micro-capsule contg. water soluble beauty-care activity component water nuclear, and composition contg. same |
| 02/16/2005 | CN1189156C Skin whitener |
| 02/16/2005 | CN1189155C Dual component tooth whitening dentifrice |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855836 5 alpha-reductase inhibitors; contraceptives; prostate disease treatments |
| 02/15/2005 | US6855835 Allomorph of isomer Z hydrochloride of alkylaminofurane derivative |
| 02/15/2005 | US6855832 O- or S-substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 02/15/2005 | US6855830 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 02/15/2005 | US6855829 3-fluoro-2-oxindole modulators of KCNQ potassium channels and use thereof in treating migraine and mechanistically related disease |
| 02/15/2005 | US6855826 1,3-butadienes, perhydrobutadienes, ethylenes and ethanes as amino acid derivatives; hypotensive agents; antidiabetic agents and (pre)eclampsia treatments |
| 02/15/2005 | US6855823 Selective iGluR5 receptor antagonists |
| 02/15/2005 | US6855820 Treating racemic 2-(chlorophenyl)-2-hydroxy-3,5,5-trimethyl-morpholinol with p-toluyl-L-tartaric acid(a chiral acid) in a suitable solvent to form a mixture of diastereomeric salts; isolating the salt, reacting with base |
| 02/15/2005 | US6855818 Vasodilation; heart imaging |
| 02/15/2005 | US6855812 P-glycoproteins and uses thereof |
| 02/15/2005 | US6855810 Ligands directed to the non-secretory component, non-stalk region of plgR and methods of use thereof |
| 02/15/2005 | US6855802 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy |
| 02/15/2005 | US6855770 Drug delivery compositions and medical devices containing block copolymer |
| 02/15/2005 | US6855736 Molecular target of neurotoxicity |
| 02/15/2005 | US6855735 Ketamine treatment of restless legs syndrome |
| 02/15/2005 | US6855734 Glycine betaine and its use |
| 02/15/2005 | US6855733 Formulation and manufacturing process for coenzyme Q10 soft gel capsules |
| 02/15/2005 | US6855732 Containing one or more optionally hydrogenated substituted styryl groups; especially 3-(3,5-dimethoxyphenyl)-2-(p-(p-(2,2-bis(methoxycarbonyl)-viny l)phenoxy)phenyl)acrylic acid |
| 02/15/2005 | US6855729 Such as the racemic substance RS pindolol |
| 02/15/2005 | US6855728 Small-molecule modulators of hepatocyte growth factor / scatter factor activities |
| 02/15/2005 | US6855727 Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect |
| 02/15/2005 | US6855726 Heterocyclic amides such as 3-(1-5-((2R,6S)-2,6-dimethyltetra-hydro-1(2H)-pyridinyl)pentyl-2-oxo-1,2 -dihydro-3-quinolinyl) benzenecarboximidamide, administered as anticoagulants or for prophylaxis of cardiovascular disorders |
| 02/15/2005 | US6855723 Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855721 Administering aminobutyric acid receptor modulators such as 2-(7-chloro-1,8-naphthyridine-2-yl)-3-(5-methyl-2-oxo-hexyl) -1-isoindolinone for prophylaxis of nervous system and developmental disorders |
| 02/15/2005 | US6855719 Nitrogen compounds such as 2-(3-Chloroanilino)-4-(2-methyl-imidazo(1,2a)pyrid-3-yl)pyrimidine, used as cyclin dependent kinase inhibitors or as anticarcinogenic agents |
| 02/15/2005 | US6855715 Drugs such as 1-(3-Amino-4-chlorobenzoyl-D-phenylglycinyl)-4-(4-fluoro-2 -methylsulphonylphenyl)piperazine, used as anticoagulants |
| 02/15/2005 | US6855712 Combination of benzoquinazoline antifolates and protecting agents |
| 02/15/2005 | US6855711 Pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders and some novel iron chelators |
| 02/15/2005 | US6855710 Antiproliferative agents; antitumor agents |
| 02/15/2005 | US6855709 Psychological disorders; central nervous system disorders |
| 02/15/2005 | US6855707 Method for the treatment of lipid and glucose metabolism disorders |
| 02/15/2005 | US6855704 Extracting and purification of triene steroids from mammal urine by chromatography; hormone replacement therapy |
| 02/15/2005 | US6855703 Triene steroids administered to mammals for prophylaxis of diseases and disorders such as cancer, menopause or osteoporosis |
| 02/15/2005 | US6855698 Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazoles |
| 02/15/2005 | US6855697 Troxerutin with a high content of trihydroxyethylrutoside and process for its preparation |
| 02/15/2005 | US6855696 Antitumor agents |
| 02/15/2005 | US6855691 Methods for producing and using S-nitrosohemoglobins |
| 02/15/2005 | US6855689 Anticancer agents |
| 02/15/2005 | US6855686 Also administering to the subject an effective amount of an mda-7 protein. |
| 02/15/2005 | US6855668 Methods and products for inhibiting growth of fungal pathogens on turfgrass |
| 02/15/2005 | US6855520 Cell volume-regulated human kinase h-sgk |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855510 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 02/15/2005 | US6855496 Detection of preferential nucleic acid ligands; obtain nucleotide sequences, incubate with oligonucleotides, hybridize, amplify, recover nucleotide sequences |
| 02/15/2005 | US6855361 Sugar-free products with improved characteristics |
| 02/15/2005 | US6855359 Soluble isoflavone compositions |
| 02/15/2005 | US6855353 Method for producing antioxidant and prevention of cancer |
| 02/15/2005 | US6855352 Pressing and/or extraction, fruit polyphenol rich in condensed tannins (procyanidins), chlorogenic acid, and epicatechin, antibacterial antioxidative, anticancerous, antiallergic, deodoring, antiviral and blood cholesterol oxidation |
| 02/15/2005 | US6855346 Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same |
| 02/15/2005 | US6855344 Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
| 02/15/2005 | US6855342 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 02/15/2005 | US6855341 zinc compound and at least one phenolic antioxidant and a pharmaceutical carrier. |
| 02/15/2005 | US6855339 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 02/15/2005 | US6855336 Omeprazole formulation |
| 02/15/2005 | US6855334 Controlled delivery of active agents |
| 02/15/2005 | US6855333 Stabilization of solid thyroid drug formulations |
| 02/15/2005 | US6855328 Antimicrobial and antiviral compositions containing an oxidizing species |
| 02/15/2005 | US6855326 Skin disorders; protective coatings |
| 02/15/2005 | US6855317 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/15/2005 | US6855310 Aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of acetaminophen, orphenadrine or tramadol. |
| 02/15/2005 | US6855277 Method and apparatus for liposome production |
| 02/15/2005 | US6855132 Apparatus with weeping tip and method of use |
| 02/15/2005 | US6854468 Treatment of subnormal bone mineral density |
| 02/15/2005 | CA2421026C Viral inhibition by n-docosanol |
| 02/15/2005 | CA2332184C Process to lower the fusion point of type iii ceramides into a single stereoisomeric |
| 02/15/2005 | CA2323720C New substances derived from aza-indolic polycyclics, processes for preparing them and pharmaceutical compounds containing them |
| 02/15/2005 | CA2312409C New derivatives of 7-oxo-2,3,7,14-tetrehydro-1h-benzo[b]pyrano[3,2-h]acridine carboxylate, the procedure for preparing same and the pharmaceutical compounds containing same |
| 02/15/2005 | CA2303764C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 02/15/2005 | CA2275626C Homogeneous preformulations containing high concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations |
| 02/15/2005 | CA2251927C Cycloalkylaminomethylpyrrolidine derivatives |
| 02/15/2005 | CA2156821C Lidocaine aerosol anaesthetic |
| 02/15/2005 | CA2156408C Aerosol formulation containing a polyester dispersing aid |
| 02/15/2005 | CA2141056C Treatment of dentoalveolar infections with taurolidine and/or taurultam |
| 02/15/2005 | CA2124339C Novel 19-nor steroids having a thiocarbon-containing chain in the 11 beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositionscontaining said steroids |
| 02/15/2005 | CA2123232C Pharmaceutical compositions containing ebastin or analogs thereof |
| 02/15/2005 | CA2107223C Crystalline tiagabine hydrochloride monohydrate, its preparation and use |
| 02/14/2005 | WO2005024025A1 Polyene polyketides and methods of production |
| 02/14/2005 | CA2477359A1 Pyruvate enriched onion extract |
| 02/13/2005 | CA2470866A1 Uses of dorzolamide to improve night vision |
| 02/12/2005 | WO2005016080A2 Folding table and bench system |
| 02/12/2005 | CA2481451A1 Folding table and bench system |
| 02/12/2005 | CA2437266A1 Taste-masked resinate and preparation thereof |
| 02/12/2005 | CA2436979A1 Methods for preventing neurological events |
| 02/10/2005 | WO2005012901A2 Method for measuring aromatase activity |
| 02/10/2005 | WO2005012870A2 Improved aminodextran compositions and conjugates and methods of making and using them |
| 02/10/2005 | WO2005012544A2 Methods for the identification of inhibitors of mannosyltransferase and mannosyltransferase complex subunit as antibiotics |
| 02/10/2005 | WO2005012543A2 Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |